Archive for November, 2010

marcus evans Summits announces Patrick J. Ellingsworth, Chairman at the European Tax Summit 2011

Monday, November 29th, 2010

26 November 2010

marcus evans Summits, is pleased to announce Patrick J. Ellingsworth as the Chairman at the fifth annual European Tax Summit, on the 13-15 March 2011, taking place at the prestigious Fairmont Le Montreux Palace, Montreux, Switzerland.

The European Tax Summit (www.taxsummit.com/GTMpr), will highlight the tax profession’s current objectives and future ambitions through visionary keynote presentations and case studies delivered by your most esteemed peers in the tax practitioner community. The one-to-one meetings with leading solution and service providers will offer you the expertise needed to operate an efficient corporate tax machine that will ultimately play a core role in your business.

Patrick J. Ellingsworth is a Former Chair of the Tax Committee of the Business & Industry Advisory
Committee (BIAC) to the Organization for Economic Co-operation & Development (OECD) in Paris and a Governing Trustee of the International Bureau of Fiscal Documentation (IBFD) in Amsterdam. Keynote Speakers also include Gottfried Schellmann, Chairman of Fiscal Committee, Confédération Fiscale Européenne; Urs Kapalle, Director Taxation and Fiscal Policy, Swiss Bankers Association; John Christensen, Director of the International Secretariat, Tax Justice Network; Krister Andersson, Chairman Tax Policy Group, BUSINESSEUROPE; Jim Robertson, VP Tax, Eastern Hemisphere & Global Tax Practices, Shell International; Daniel Mitchell, Senior Fellow, Cato Institute and Melchior Wathelet, Minister of State for Belgium, Former ECJ Judge & Professor of European Law, University of Louvain and Liège.

This year’s European Tax Summit audience includes Senior Vice Presidents of International Tax, Vice Presidents of Tax, Chief Tax Officers, Group Heads of Tax, Heads of Transfer-Pricing, Tax Directors, Tax Counsels, International Tax Managers, Heads of Direct and Indirect Tax as well as Sponsors offering a wide range of product / service categories / including Tax Consulting Services, Tax Management, Legal Services, International Tax Planning and Tax Outsourcing.

marcus evans Summits (www.marcusevans.com), produces high level business platforms for the world’s leading decision-makers. These dynamic and innovative forums initiate and develop business relationships one to one between director and C level practitioners from the world’s most influential organizations and with leading product and service suppliers. marcus evans Summit’s guarantees an exclusive format which enables participants to achieve the maximum amount of business and knowledge interaction over a three day event in a stimulating environment.

Please note that the European Tax Summit is a closed business event and the number of participants is limited.

For more information
Daniela Trojakova
Marketing Manager
Tel: +357 22 849 380
Email: summits@marcusevanscy.com
www.taxsummit.com/GTMpr
www.marcusevans.com

People Creating Value: Aligning Visions for Superior Product Development

Friday, November 26th, 2010

Bart Velthuizen of People Creating Value, a sponsor at the marcus evans Industrial Design Summit 2010, on superior innovation in product development.

Interview with: Bart Velthuizen, Chief Executive Officer, People Creating Value

Cannes, France, November 10, 2010 – FOR IMMEDIATE RELEASE

Product design and development companies need to align their visions of technology and future consumer behaviours to enhance the chances of new breakthroughs, says Bart Velthuizen, Chief Executive Officer at People Creating Value. Companies that stand out are those who have found matches between the two. From a sponsor company at the marcus evans Industrial Design Summit 2010, in Cannes, France, 22 – 24 November, Velthuizen discusses his thoughts on aligning visions for superior innovation and creativity.

What makes a product user-centric?

Bart Velthuizen: Having a user-centric design methodology is the best way to ensure products are user-centric. Experts often ask potential consumers what their expectations of the future are, to build a picture of what people need or what they will need in the future. Product designers need to analyse and translate consumer insights into product specifications, and use that data to guide product development in a structured way.

What brings product loyalty?

Bart Velthuizen: Product loyalty comes from product quality. Manufacturers need to make simple and beautiful products which address and fulfil customer needs. The consumer will remember the quality next time he or she buys the product.

How can product design executives reach superior levels of creativity and innovation?

Bart Velthuizen: Innovation has hundreds of definitions. We chose the definition of people creating value through the implementation of new ideas. This is not about creating new ideas but implementing ideas and creating value in new ways.

Companies that stand out in the world do two things: they understand their customers’ needs and combine that with creative technology to get matches between the two.

What are some of the upcoming developments that the industry should prepare for?

Bart Velthuizen: There will be a scarcity of certain materials and we will need to find ways of using renewable or recyclable materials. There are also toxicity and environment issues to consider. The choice of material in product development is becoming more and more critical.

What long-term strategies would you recommend?

Bart Velthuizen: I would advise aligning visions of technological capabilities with visions of future behaviours. We will be seeing many companies working on brilliant ideas and not finding the right market, either because it does not exist or because there is no access to it.

If you have built a vision of how consumers are going to behave in the future you have to do the same with technology; organise a radar function to spot new and emerging technologies, and try to align those two visions into one long-term vision for your consumers and technology. Doing so will enhance the chances of finding a new breakthrough.

Sarin Kouyoumdjian-Gurunlian, Press Manager, marcus evans, Summits Division

About the Industrial Design Summit 2010

This unique forum will take place at the Majestic Barri̬re Hotel, Cannes, France, 22 Р24 November 2010. Offering much more than any conference, exhibition or trade show, this exclusive meeting will bring together esteemed industry thought leaders and solution providers to a highly focused and interactive networking event. The summit includes presentations on engineering consumer experiences, successful product development, the eco-design revolution and heightening brand loyalty.

For more information please send an email to Jana Urbanovska at news@marcusevanscy.com or visit the event website at www.industrialdesignsummit.com/media_GTM_bv

Please note that the summit is a closed business event and the number of participants strictly limited.

About marcus evans Summits

marcus evans Summits are high level business forums for the world’s leading decision-makers to meet, learn and discuss strategies and solutions. Held at exclusive locations around the world, these events provide attendees with a unique opportunity to individually tailor their schedules of keynote presentations, think tanks, seminars and one-to-one business meetings. For more information, please visit www.marcusevans.com

All rights reserved. The above content may be republished or reproduced – kindly inform us by sending an email to news@marcusevanscy.com

About People Creating Value

People Creating Value evolved from the successful collaboration between the companies De Loft and First. In September 2009, they launched People Creating Value as a design consultancy for integral product development offering an extensive range of competences.

For more information: www.peoplecreatingvalue.com

Private Wealth Management Executives Shared Best Practices at the Elite Summit 2010, organised by marcus evans

Wednesday, November 24th, 2010

A Unique Summit, Run by an Established Event Organiser

15-17 November 2010 | Fairmont Le Montreux Palace | Montreux | Switzerland

As the aftershocks of the economic crisis continue to disrupt markets worldwide, some of Europe’s top private wealth management industry executives came together at the recent marcus evans Elite Summit 2010, the leading private wealth management event, to share insights and strategies for unearthing the opportunities in today’s highly volatile investment landscape.

The Elite Summit (www.elitesummit.com/GTMpr) is a premium biannual forum for key decision makers from Europe’s most prominent family offices, trusts, foundations and endowments. The event focused on key wealth planning priorities, investment management efficiencies and lifestyle enhancements. The Elite Summit allowed participants to increase their depth of knowledge in critical areas pertaining to family wealth, while having the unique opportunity to take part in one-to-one meetings with leading wealth management service providers.

The summit attendees followed a personalised agenda designed to maximise their limited time and to effectively meet their business needs and interests. Keynote Speakers included:

- Constantinos G Grigoriades, CIO, Alpanco
- Denise Kenyon-Rouvinez, PhD, Head of International Family Business & Philanthropy, RBS Coutts BankDaniel Mateos, Director, Werner Capital
-Marc A Moret, LLM, Founder, Lobnek Wealth Management
- Osmond Plummer, Swiss Correspondent, Wealth Briefing, Managing Director, Wealth Coaching
- Russell Prior, Executive Director, Enterprise & Philanthropy Development, Charities Aid Foundation
- Dr Wolfgang Seidel, Finance Professor, ESCP Europe Business School
- Dr jur Frederick Metz Shepperd, Managing Director, Shepperd Investors

Testimonials

“Great organization, quality speakers combined with the opportunity to network with other family offices.”

Investment Manager, Cluster Family Office

Very enjoyable and educational. Love to join next year.
Vice President, KIRKBI A/S

“At marcus evans, it is all about total quality management, all efforts are geared towards achieving excellence, highly committed and entrepreneur staff, great selection of speakers, that make the venue a value proposition to all.”

Managing Partner, Coris Family Office

“Great organisation, great networking, the best by definition!!”
CIO, Prisminvest SA

marcus evans Summits (www.marcusevans.com), produces high level business platforms for the world’s leading decision-makers. These dynamic and innovative forums initiate and develop business relationships one to one between director and C level practitioners from the world’s most influential organisations and with leading product and service suppliers. marcus evans Summit’s guarantees an exclusive format which enables participants to achieve the maximum amount of business and knowledge interaction over a three day event in a stimulating environment.

Please note that the Elite Summit is a closed business event and the number of participants is limited.
For more information

Daniela Trojakova
Marketing Manager
Tel: +357 22 849 380
Email: summits@marcusevanscy.com
www.elitesummit.com/GTMpr
www.marcusevans.com

Dr Wolfgang Seidel: The Allure of Equities and Commodities

Thursday, November 18th, 2010

Wolfgang Seidel, a keynote speaker at the marcus evans Elite Summit 2010 and Private Wealth Management Summit Fall 2010, explores the upcoming investment opportunities.

Interview with: Dr Wolfgang Seidel, Finance Professor, ESCP Europe Business School

Nicosia, Cyprus, November 18, 2010 – FOR IMMEDIATE RELEASE

Equities and commodities offer very attractive investment opportunities, says Wolfgang Seidel, Finance Professor at ESCP Europe Business School. The performance drivers will be low valuations for equities and above-trend growth for commodities. A keynote speaker at the marcus evans Elite Summit 2010 in Montreux, Switzerland, and Private Wealth Management Summit Fall 2010 in Las Vegas, Nevada, Seidel shares his opinion on the asset classes and sectors that family offices can capitalise on, and why equities and commodities should appeal to long-term investors.

How should family office directors position themselves?

Wolfgang Seidel: With 2010 moving toward its end the macroeconomic situation is highly precarious. Concerns are both, deflation and inflation, the European sovereign debt situation and currency interventions potentially leading to wider capital controls and trade barriers. Short term, I would therefore recommend to stay liquid in order to be able to react fast. Being vigilant and having a plan B in the drawer should help investors to move quickly.

Which asset classes and sectors would you recommend?

Wolfgang Seidel: On a one-year time scale, equities and commodities have good prospects. EU and US equities are highly attractive in terms of both, absolute valuations such as P/Es & P/Bs and relative valuations such as dividend yields against real treasury yields & equity risk premiums. Earnings development and earnings sentiment do also look favourable.

Stock picks should be guided by two themes: Many institutional investors are looking at high dividend stocks to replace part of their low yielding fixed income holdings; and economic growth and valuation multiples are high in EMs, but low in DMs. I would therefore favour companies with high dividends/dividend growth and companies listed in DMs with high sales exposure to EMs.

The demand for commodities is driven by global above-trend growth, particularly in emerging markets, where the commodity-intensity per unit of GDP is higher at the margin. As a consequence, commodities with a high sensitivity for the level of growth such as energy and industry metals are attractive. Additional roll yields are achievable with e.g. copper.

In addition, due to the low level of interest rates and a second round of quantitative easing there is a good case for a continuation of the precious metals surge.

Any untapped investment opportunities?

Wolfgang Seidel: Owing to the strong growth of the world population, limited availability of arable land, change of nutritional habits and abating production yield increases there is a strong macro case for soft commodities. Because of negative roll yields in the commodity futures space this segment has to be addressed through direct farmland investments in highly productive countries with still price-inefficient markets such as Brazil. Key will be to find the right investment managers with local presence and networks.

The same demographic and nutritional factors feed into a much higher future demand for water that will cause significant shortages. Water sources will appreciate substantially in value.

Another area is real assets in the oil and gas space, which seems underserved by dedicated fund managers. There are lots of inefficiencies that need specialised expertise, e.g. depleted oil fields that can get extracted further because a) higher oil price levels allow higher deployment of capex, and/or b) modern technologies allow substantially deeper depletions.

More liquid ideas are underpriced EuroStoxx dividend futures and Argentina GDP warrants.

If you had one message to family offices, what would it be?

Wolfgang Seidel: We won the war but we struggle to sustain the peace. In this uncertain economic environment extraordinary vigilance is indispensable.

Contact: Sarin Kouyoumdjian-Gurunlian, Press Manager, marcus evans, Summits Division

For more information please send an email to Daniela Trojakova at news@marcusevanscy.com or visit the event websites below:

Elite Summit 2010 – Montreux, Switzerland:
http://www.elitesummit.com/media_gtm_ws

Private Wealth Management Summit Fall 2010 – Las Vegas, Nevada:
http://www.privatewealthsummit.com/media_GoingToMeet_ws

About marcus evans Summits

marcus evans Summits are high level business forums for the world’s leading decision-makers to meet, learn and discuss strategies and solutions. Held at exclusive locations around the world, these events provide attendees with a unique opportunity to individually tailor their schedules of keynote presentations, think tanks, seminars and one-to-one business meetings. For more information, please visit www.marcusevans.com

All rights reserved. The above content may be republished or reproduced. Kindly inform us by sending an email to news@marcusevanscy.com

Commercialization Strategies & Market Access for Personalized Medicines & Companion Diagnostics

Thursday, November 11th, 2010

Header

Theme: Realizing the economic feasibility and best-practice business models of the Rx/Dx revolution

Venue: Miami, Florida, USA
Conference Dates: February 9th & 10th, 2011

Pharma manufacturers need to make strategic decisions whether using biomarkers to segment the patient population and the potential market size, makes sounds business sense compared to pursuing a blockbuster strategy. Partnerships between pharma companies and molecular diagnostics companies are often the way forward, but questions remain with regards to final IP and product ownership, legal and contractual issues and marketing rights. Various possible R&D and business models exist, whether developing drug and biomarker in-house, outsourcing or partnering, but no one really knows yet which models define “best practice”. During research and development, there are also many scientific and regulatory obstacles that also need to be overcome for more promising Dx/Rx products combinations to reach the market.

At the same time, payers and health technology assessors are increasingly looking for more value for money in health spending. Many such organizations maintain that they are willing to invest in drugs that offer significantly improved levels of patient safety and efficacy, if somehow clinical outcomes data can provide compelling evidence of real added value. More and more HTA agencies are realising the potentially strong benefits of reimbursing drugs that are targeted towards a genetically defined patient population, rather than the current “one drug for all” approach of blockbusters. Although, many questions remain unanswered, including how much extra payers are really willing to invest in reducing risk via higher-priced drugs designed for a smaller marketplace and to what extent they are prepared to pay for expensive genetic diagnostic tests that accompany them.

Why attend?

  • Gain a complete understanding and overview of the economic and business realities and potential of personalized healthcare today and in the future
  • Find out if the blockbuster strategy is alive or dead in the eyes of industry experts, payers and health technology assessors
  • Understand how to design and implement a commercially viable business model for both drugs and companion diagnostics
  • Discover how to overcome scientific, technical, regulatory, intellectual property hurdles to launching pharmacogenomics products
  • Determine the real market value of personalized medicines and companion diagnostics in terms of how much payers are willing to invest in such innovation and how to gain access

Who Will Benefit?
Pharma, Biotech, Diagnostic companies
CEOs, Vice-Presidents, Directors, Senior Managers of:

Personalized Medicine, Business Development, Heads of Therapeutic Area, Corporate & Strategic Marketing, Health Economics and Outcomes Research, Market Access, Pricing & Reimbursement, Heads R&D, Biomarker R&D, Chief Scientific Officers, Heads of Discovery, Portfolio Management.

Other Stakeholders: Ministries of Health, Health Technology Assessors, Academia & Policy Makers
Agenda request
To request the full agenda please follow the link:

http://www.nextlevelpharma.com/events/request_agenda/commercialization_strategies_market_access_for_personalized_medicines_companion_diagnostics

For Booking Information contact:

Erika Vavrovicova

Tel: +421 232 660 382
Fax: +421 2 3301 0331
Email: erika@nextlevelpharma.com
Visit: www.nextlevelpharma.com

Pharmaceutical Market & Patient Access In Latin America

Thursday, November 11th, 2010

Pharmaceutical Market & Patient Access In Latin America header

Theme: Demonstrating value to payers in the complex emerging markets of South & Central America

Conference Dates: 7th & 8th February, 2011
Venue: Miami, Florida, USA

This event will provide participants with a regional overview, as well as specific detail of the market access, pricing and reimbursement environment in key Latin American countries such as Brazil, Mexico, Argentina, Columbia, Venezuela, Chile, Panama, Costa Rica, among others. A thorough understanding will be achieved by hearing the perspectives of payers, government officials and key opinion leaders from academia, as well as learning from the case-study experiences from pharma industry veterans who have successfully overcome challenges to launch innovative medicines in this exciting region.

Why Attend?

  • Discover how payers are viewing risk-sharing agreements and what are their initiatives in the field.
  • Learn how innovation is being rewarded and how market leaders are dealing with generic competition in the region.
  • Understand the markets’ affordability and willingness to reimburse high-cost drugs.
  • Learn how to demonstrate product value to local HTA agencies, regulators and payers.
  • Hear multi-stakeholder perspectives from: pharmaceutical industry, academia, HTA, policy-makers.
  • Benchmark, network and co-operate with pharma & non-pharma decision makers.
  • View the regional picture of market growth and market Access in Latin America.
  • Get up to date on the development and establishment of health technology assessment in leading Latin American markets.

Who will benefit?
Pharmaceutical companies:
Vice-Presidents, Directors, Managers involved in: Market Access, Pricing & Reimbursement, Health Economics & Outcomes, Government & Stakeholder Relations, Regulatory Affairs, Medical Affairs, Marketing, Therapy Area Heads, Country Managers
Solution providers & consultants:
CEOs, Business Development, Senior Consultants, Regional Heads
Plus:
Independent Academics, Health Economists, Senior Doctors, & Patient Representatives.

Agenda request
To request the full agenda please follow the link:

http://www.nextlevelpharma.com/events/request_agenda/pharmaceutical_market_patient_access_in_latin_america

For Booking Information contact:
Erika Vavrovicova

Tel: +421 232 660 382
Fax: +421 2 3301 0331
Email: erika@nextlevelpharma.com
Visit: www.nextlevelpharma.com

Adapting to a New Reality: The Impact of the Health Care Reform on Medical Device Manufacturing

Wednesday, November 10th, 2010

Thomas Novelli, the Chairman of the marcus evans Medical Device Manufacturing Summit Fall 2010, talks about improving efficiency and preparing for upcoming changes in the industry.

Interview with: Thomas Novelli, Vice President of Government Affairs, Medical Device Manufacturers Association

Hollywood, FL, September 16, 2010 – FOR IMMEDIATE RELEASE

The medical device manufacturing industry needs to find ways of cutting costs and minimizing the impact of future excise taxes that the Health Care Reform will bring about, advises Thomas Novelli, Vice President of Government Affairs at the Medical Device Manufacturers Association. The Chairman of the marcus evans Medical Device Manufacturing Summit Fall 2010 taking place in Hollywood, Florida, December 5-7, Novelli discusses the need for cost cutting and where the opportunities for leaner production may lie.

What are some of the upcoming changes that medical device manufacturers should be prepared for?

Thomas Novelli: In the next few years, medical device manufacturing executives will have to adapt to the changes made in the new healthcare laws. One issue that will directly impact them is the 2.3 percent excise tax, therefore they will need to find ways to minimize this effect.

Looking forward, executives have to find much leaner production methods, cutting costs where possible. For example, they can look at their supply chain management systems. They should be finding more efficient approaches, minimizing distribution delays and executing high-quality manufacturing practices, such as six-sigma.

What long-term strategies would you suggest?

Thomas Novelli: In supply chain management systems, mid-sized companies are not as efficient as they could be. It is essential for them to look at the best practices in the industry – this could be industry leaders, or small companies like themselves. By looking at these practices, they can learn what they need to do to improve their Just-in-Time strategies and make sure that the product lifecycle process is being implemented and utilized to its fullest potential.

Medical device manufacturers should also be aware of new disclosure requirements. The law provisions require device manufacturers to disclose the payments that they make. In addition, they need to be prepared for the research division of the litigation, as a private public entity called The Patient’s Centre of Malcolm’s Research Institute will start to guide pairs within the healthcare system, such as Medicare and Medicate, and provide them with evidence on medical interventions, drugs, devices, and more. My advice is: target equipment gain, as technology is always moving forward, and the appropriate evidence is going to help you not only secure regulatory purpose problems, but reimbursement as well.

How can innovation in medical device manufacturing be enhanced?

Thomas Novelli: In order for innovation to take place, there has to be a favorable environment. The medical device industry is different from the pharmaceutical industry, in the sense that most of the innovation takes place in small or mid-sized companies. These smaller companies are developing innovative technologies and commercializing them themselves, or being acquired by larger corporations.

To have a favorable regulatory and legislative environment, there must be a clearly proven medical technology. In recent years, the Food and Drug Administration (FDA) has become less predictable and timely for device application approval with the agency. This has led to a back-up of applications and venture capitalists who have invested in these companies and are choosing to stop due to problems they are seeing in the FDA. In order for investors to continue to invest and promote innovation, this situation must be resolved.

Contact: Sarin Kouyoumdjian-Gurunlian, Press Manager, marcus evans, Summits Division

About the Medical Device Manufacturing Summit Fall 2010

This unique forum will take place at The Westin Diplomat Resort & Spa, Hollywood, Florida, December 5-7, 2010. Offering much more than any conference, exhibition or trade show, this exclusive meeting will bring together esteemed industry thought leaders and solution providers to a highly focused and interactive networking event. The summit includes presentations on lean manufacturing, supply chain and risk management, and staying ahead of FDA regulations.

For more information please send an email to Jana Urbanovska at news@marcusevanscy.com or visit the event website at http://www.medicalmanufacturingsummit.com/media_GTM_tn

Please note that the summit is a closed business event and the number of participants strictly limited.

About marcus evans Summits

marcus evans Summits are high level business forums for the world’s leading decision-makers to meet, learn and discuss strategies and solutions. Held at exclusive locations around the world, these events provide attendees with a unique opportunity to individually tailor their schedules of keynote presentations, think tanks, seminars and one-on-one business meetings. For more information, please visit http://www.marcusevans.com

All rights reserved. The above content may be republished or reproduced – kindly inform us by sending an email to news@marcusevanscy.com

The Do’s and Dont’s of Product Development Planning

Wednesday, November 10th, 2010

Christian Haller from MPR Product Development, a solution provider at the marcus evans Medical Device R&D Summit 2010, shares his thoughts on the most effective product development planning strategies.

Interview with: Christian Haller, Director MPR Product Development

Las Vegas, NV, July 2, 2010 – FOR IMMEDIATE RELEASE

Medical device Research and Development (R&D) directors very often come up with brilliant product ideas but do not necessarily plan the development process properly, according to Christian Haller, Director MPR Product Development. They end up spending substantially more time and money developing a product than they really need to. A solution provider at the marcus evans Medical Device R&D Summit 2010 taking place in June 20-22, Haller discusses best practices for product development and risk management.

What long-term strategies and best practices would you recommend?

Christian Haller: One of our primary approaches is to manage risks; not only technical risks but product and development risks, such as marketing, reimbursement, and regulatory approval. In our experience, many companies do not put sufficient effort upfront into planning out a detailed vision of what the product is, how it is going to be used and paid for, the business case of the product from the buyer’s point of view, and the user experience. While mostly everyone gets around to these activities, much time and effort can be saved by spending more time up front on these issues.

Medical device R&D directors should take more time planning, talking to potential users to find out what they really want from the product, and identifying how the product fits into the business model, not only as a manufacturer but how it fits into the consumers’ business model. They need to focus on the final outcome as early on as possible. This will mean fewer changes in the development process. Very often, people come up with an initial idea but do not think through all of these issues and they have to continually redefine the image of the product. They spend more time re-developing the product and as a result, substantially more money than they really need to.

These strategies also help in decreasing the time to market. We have reduced our average time of filing very complex devices to a year or just under. Compared to industry averages, we are proud of this metric. Of course, you cannot guarantee how long the US Food and Drug Administration (FDA) will take to approve a product, but planning upfront and a proactive approach with the FDA helps speed things up.

What challenges are medical device R&D directors in North America facing?

Christian Haller: The market is focused on coming up with new products with fewer resources. Many companies are cutting R&D budgets ahead of the taxes on medical devices, which will be imposed by the Health Care Reform Bill. People will have to keep doing more with less, in addition to having to come up with products that work better in order to be approved for use by the Bill.

There are also significant modifications to the FDA rules which we are not used to; there are many unknowns in that regard. From our experience, it is important to take a cooperative and proactive approach with regulators. R&D directors should spend a lot of time on due diligence and determining the best regulatory strategies, going to the FDA with their plans, defining their own recommended regulatory path and working to build consensus upfront. You have to be your own advocate with the FDA. Talk early and talk often, is what we tell to our clients.

How can the product lifecycle be extended?

Christian Haller: In the effort to get to the market quicker, we advise clients not to add too many features that are not absolutely essential. We have found that one of the best ways to extend the lifecycle of a product is to define the architecture of the device, so that additional features and applications can be added cost effectively later on. By defining the architecture appropriately, you enable the ability to refresh the product at a later stage.

When outsourcing parts of the R&D process, how can manufacturers ensure everything is in sync?

Christian Haller: Firstly, they need a detailed written plan from all solution providers that covers the entire development process. When we start a project, we give the client a very detailed plan covering all the stages of the project, all the deliverables and activities defined, with a detailed listing of what will and will not be included. It is important to communicate that effectively. Everything should be written down, from beginning to end. The two parties have to reach complete agreement on the plan and the review process before starting.

Secondly, the parties have to establish regular scheduled meetings, perhaps once a week either in person or via teleconference, to walk through the status of the job.

Thirdly, it is necessary to have a team at the outsourced end that is dedicated, and a project manager who is constantly in contact with the client, who will oversee the project from beginning to end. The team at the outsourced company should be an extension of the manufacturer’s own development team.

Lastly, the way we see it, it is more efficient to have third party suppliers who can do the entire job. One could hire a software company, an electronics company, and a mechanical design company, but that generally means getting all those different outsourced resources working together harmoniously, often a full time job. Going to a company with a proven track record that is able to do the entire job is key. People will be more motivated to cooperate with each when there are fewer companies involved.

Contact: Sarin Kouyoumdjian-Gurunlian, Press Manager, marcus evans, Summits Division

About the Medical Device R&D Summit 2010

This unique forum will take place at the Red Rock Casino Resort & Spa, Las Vegas, Nevada, June 20-22, 2010. Offering much more than any conference, exhibition or trade show, this exclusive meeting will bring together esteemed industry thought leaders and solution providers to a highly focused and interactive networking event. The summit includes presentations on emerging technologies, speeding product development and addressing the challenges of outsourcing.

For more information please send an email to Jana Urbanovska at news@marcusevanscy.com or visit the event website at www.medicalrdsummit.com/media_GTM_ch

Please note that the summit is a closed business event and the number of participants strictly limited.

About marcus evans Summits

marcus evans Summits are high level business forums for the world’s leading decision-makers to meet, learn and discuss strategies and solutions. Held at exclusive locations around the world, these events provide attendees with a unique opportunity to individually tailor their schedules of keynote presentations, think tanks, seminars and one-on-one business meetings. For more information, please visit www.marcusevans.com

All rights reserved. The above content may be republished or reproduced kindly inform us by sending an email to news@marcusevanscy.com

Facing the future with confidence! Preparing the African Utility for the changing power paradigm at African Utility Week

Wednesday, November 10th, 2010

From 14 – 17 March 2011, African Utility Week will provide training, networking and discussion platforms which demonstrate how utilities can prepare themselves for the changing utility landscape. With increased emphasis on smart technology and communications, renewable energy integration and diversified generation technologies, utilities are moving into a changing, exciting and challenging utility environment.

The event, taking place at the ICC in Cape Town, South Africa, provides un-missable networking opportunities! Meet key stakeholders from the whole power ecosystem, including other utilities, government stakeholders, regulators, power pools and vendors.

The exciting line up of speakers covers all of the key issues for the utility sector. The 7 break-out sessions offer opportunity for in-depth examination of some of the key issues affecting the power sector in Africa. The plenary session is going to be examining the role that an integrated resource plan could play in securing the water and power sectors in Africa. Panellists in this session include Jasper Oduor, Secretary General of the East African Power Pool and Elham Ibrahim, Commissioner of energy and Infrastructure from the African Union Commission.

Additional key experts who will be sharing insights, include

  • Metering, Billing/CRM Africa: Dr. Nicholas Smart-Yeboah, Director of Customer Service from the Electricity Company of Ghana, who will be sharing insights as to why the Ghanaian government took the step of installing pre-paid meters in the offices of ministries and other government agencies. Rudi Strubbe, Regional Vice President from Alcatel-Lucent will be speaking on smart grid ready AMI and Rens Bindeman, Managing Director of Revenue Investigations SA, will give practical steps for preparing a revenue protection strategy.

  • Smart Grids/T&D Africa: We welcome to African Utility Week Guido Bartels, Chairman of the GridWise Alliance, who will provide an idea of why utilities should consider transitioning to a smart grid. As a follow-up to that, Minnesh Bipath, Senior Manager: End Use and Infrastructure from Saneri, will discuss the regulatory requirements for smart grid integration. Integrating embedded generation into distribution networks is a topic which will be highlighted by Clinton Carter-Brown from Eskom.

  • Generation Africa: An overview of the South African Integrated Resource Plan will be presented by Omphi Aphane, Acting DG of Electricity, Nuclear and Clean Energy from the Department of Energy, SA. Anyone interested in this topic should not miss this presentation. Another interesting presentation is an evaluation of regulatory reform to boost private investment for generation in Africa by Mossad Elmissiry, Head of Bioenergy Policy, AU/Nepad (NPCA).

  • Renewable Energy Africa: We’ll also examine some project implementations, in particular Hopefield in the Western Cape and Lake Turkana in Kenya. Evans Kidero, CEO of Mumias Sugar in Kenya, will be sharing experiences with feed-in tariffs and co-generation and this will be interesting for anyone wanting to understand how the Kenyan experience has worked.

  • Large Power Users Forum: This is a vitally important issue in South Africa (and the rest of the continent) – Barry Bredenkamp, who is the General Operations Manager for the National Energy Efficiency Agency, will share the business case for energy efficiency with the audience while Valerie Geen from the National Business Initiative will discuss responses to the energy efficiency challenge. One of the key challenges to South Africa at the moment is the issue of energy security and this will be examined in detail with presentations from Kannan Lakmeeharan, Divisional Executive, System Operations and Planning from Eskom, and Leslie Rencontre, Director of Electricity Services from the City of Cape Town. Any large consumer of power should ensure they are in Cape Town during African Utility Week to get first hand insight of how to increase productivity while lowering energy costs.

For more information on the programme, please contact the programme director, Claire Volkwyn: claire.volkwyn@spintelligent.com / (021) 700 2559 or visit the conference website www.african-utility-week.com

ENERGY INDABA SECURES WORLD ENERGY COUNCIL AFRICA MEETING

Tuesday, November 9th, 2010

Energy Indaba Header

The Annual Energy Indaba has again secured the support of the World Energy Council (WEC) through the hosting of the Africa Regional Meeting as a side event of the main forum. The World Energy Council, formed in 1923, is the only truly global and inclusive forum for thought-leadership and tangible engagement committed to our sustainable energy future. The Council comprises a network of 93 national committees represents over 3000 member organizations including governments, industry and expert institutions across the globe.

The Africa Regional Meeting will bring a host of African participants from across the continent to debate and discuss issues pertinent to development of the continent, including issues relating to energy poverty and access to funding, as examples. Liz Hart, Managing Director of the Energy Indaba, added, “We are delighted to once again host the World Energy Council Africa Regional Meeting, which we believe adds impetus to the work and outcomes we are aiming to achieve for Africa. Our ultimate aim is to find solutions to Africa’s energy challenges and to address energy poverty for the people of Africa.”

The Meeting will be hosted on the 3rd March at the Sandton Convention Centre and will focus on the Africa Work programme of WEC for 2011. The Energy Indaba will be chaired by Brian Statham, SANEA Chairman and Chairman of Global Studies at the World Energy Council. Statham commented that SANEA and the WEC are pleased to be associated with the Energy Indaba because of its focus on finding solutions and mechanisms for successful implementation. The structured programme and resulting dialogue creates the platform for real progress towards realizing Africa’s vast potential.

ENDS

November 9 2010

About the Energy Indaba: Energy Indaba 2011 will be held from the 1 to 3 March 2011, at the Sandton Convention Centre, Johannesburg, South Africa. The conference continues to grow and has become the foremost forumfor debating Africa’s energy solutions and focuses on: African power suppliers; alternative and renewable energies; oil and gas; the legal and regulatory framework, and investment opportunities in African energy projects. The exhibition has become a significant market-place for African and international stakeholders doing business in Africa’s energy sector.

CONTACTS:

Press Release prepared by:

Siyenza Management (Pty) Ltd
Liz Hart
liz@siyenza.za.com
011 463 9184